MedPath

The effects of traditional medicine Product on oligomenorrhea

Not Applicable
Recruiting
Conditions
Oligomenorrhea.
Secondary oligomenorrhoea
Registration Number
IRCT2015063022987N1
Lead Sponsor
Vice Cancellor for Research,Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria

Patients with oligo/Amenorrhea; Aged between 18 to 40 years; Negative pregnancy test; Patient satisfaction .
Exclusion criteria: Pregnancy or breast-feeding; Abnormal prolactin levels ;Abnormal thyroid function tests ; FSH> 20 IU / L ;History of organic diseases or gynecological neoplasia;History of chronic renal or hepatic diseases; Severe drug allergy or a history of severe reactions toward unusual plants; Use of Ciprofloxacin, dopamine agonists and antagonists, anti androgens and estrogens; History of any type of chemical hormonal products in 1 month ago; Patients who need other interventions and surgery; Patients with a personal decision to exit from the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Start of bleeding. Timepoint: Before intervention and 1, 2 & 3 months later. Method of measurement: Question.;FSH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;LH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;Total testosterone. Timepoint: Beginning & end of study. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: During the study. Method of measurement: Question.
© Copyright 2025. All Rights Reserved by MedPath